Biomedical Systems' electronic clinical outcome assessment (eCOA) technology is used for clinical trials in more than 40 countries
Biomedical Systems launches its second generation clinical outcome assessment software offering three easy-to-use platforms to collect patient data. This new electronic patient recorded outcome (ePRO) technology improves patient and investigator user experience, improves patient compliance and expedites study setup by simplifying site tasks and reducing errors.
Biomedical Systems' electronic clinical outcome assessment (eCOA) technology is used for clinical trials in more than 40 countries for multiple therapeutic areas including respiratory, gastrointestinal, dermatology, oncology and women's health.
"The eCOA market is growing fast, and launching this technology enhances our ability to offer centralized diagnostic services. In 40 years, Biomedical Systems has built a premier global presence based on centralized diagnostic services and logistics excellence. Our eCOA solutions will extend that prompt, reliable global service we're known for to provide more reliable data while collecting data for primary and secondary endpoints," said Mr Tim Barrett, chief executive officer at Biomedical Systems.